XML 39 R18.htm IDEA: XBRL DOCUMENT
v3.21.1

Stock Incentive Plan | 12 Months Ended
--- | ---
Jan. 30, 2021
Share-based Payment Arrangement [Abstract] |
Stock Incentive Plan | Stock Incentive Plan TJX has a Stock Incentive Plan under which options and other share-based awards may be granted to its directors, officers and key employees. This plan has been approved by TJX’s shareholders, and all share-based compensation awards are made under this plan. The Stock Incentive Plan, as amended with shareholder approval, has provided for the issuance of up to 695.7 million shares with 33.9 million shares available for future grants as of January 30, 2021. TJX issues shares under the plan from authorized but unissued common stock. Total compensation cost related to share-based compensation was $59 million, $125 million and $104 million in fiscal 2021, 2020 and 2019, respectively. As of January 30, 2021, there was $149 million of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the plan. That cost is expected to be recognized over a weighted-average period of 2 years. Stock Options Options for the purchase of common stock are granted with an exercise price that is 100% of market price on the grant date, generally vest in thirds over a 3-year period starting 1 year after the grant, and have a 10-year maximum term. When options are granted with other vesting terms, the vesting information is reflected in the valuation. The fair value of options is estimated as of the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:
| Fiscal Year Ended
| January 30, 2021 | February 1, 2020 | February 2, 2019
Risk-free interest rate | 0.28 | % | 1.65 | % | 2.88 | %
Dividend yield(a) | 1.4 | % | 1.6 | % | 1.4 | %
Expected volatility factor | 26.5 | % | 23.4 | % | 23.5 | %
Expected option life | 5.0 years | 4.9 years | 4.9 years
Weighted average fair value of options issued | $ | 11.29 |  | $ | 10.84 |  | $ | 11.85 |
(a)The reduction in the yield reflects the temporary suspension of dividends due to the COVID-19 pandemic. TJX calculated an implied dividend yield of 1.4% by anticipating dividends to resume. The decrease in expected dividend yield reflects the suspension of dividend payments during the first nine months of fiscal 2021. The risk-free interest rate is for periods within the contractual life of the option based on the U.S. Treasury yield curve in effect at the time of grant. The Company uses historical data to estimate option exercises, employee termination behavior and dividend yield within the valuation model. Expected volatility is based on a combination of implied volatility from traded options on our stock, and historical volatility during a term approximating the expected life of the option granted. The expected option life represents an estimate of the period of time options are expected to remain outstanding based upon historical exercise trends. Employee groups and option characteristics are considered separately for valuation purposes when applicable. A summary of the status of TJX’s stock options and related weighted average exercise prices (“WAEP”) is presented below:
| Fiscal Year Ended
Shares in thousands | January 30, 2021 | February 1, 2020 | February 2, 2019
| Options | WAEP | Options | WAEP | Options | WAEP
Outstanding at beginning of year | 45,065 |  | $ | 36.81 |  | 49,053 |  | $ | 32.02 |  | 55,260 |  | $ | 27.52 |
Granted | 6,268 |  | 57.32 |  | 6,150 |  | 56.74 |  | 6,143 |  | 53.98 |
Exercised | (8,239) |  | 25.68 |  | (9,518) |  | 24.40 |  | (11,670) |  | 21.88 |
Forfeitures | (490) |  | 52.96 |  | (620) |  | 46.37 |  | (680) |  | 38.59 |
Outstanding at end of year | 42,604 |  | $ | 41.79 |  | 45,065 |  | $ | 36.81 |  | 49,053 |  | $ | 32.02 |
Options exercisable at end of year | 30,659 |  | $ | 36.05 |  | 32,276 |  | $ | 31.04 |  | 34,344 |  | $ | 26.95 |
The total intrinsic value of options exercised was $279 million in fiscal 2021, $293 million in fiscal 2020 and $284 million in fiscal 2019. The following table summarizes information about stock options outstanding that were expected to vest and stock options outstanding that were exercisable as of January 30, 2021:
| Shares (in thousands) | Aggregate Intrinsic Value (in thousands) | Weighted Average Remaining Contract Life | WAEP
Options outstanding expected to vest(a) | 11,060 |  | $ | 82,510 |  | 9.0 years | $ | 56.58 |
Options exercisable | 30,659 |  | $ | 858,015 |  | 5.0 years | $ | 36.05 |
Total outstanding options vested and expected to vest | 41,719 |  | $ | 940,525 |  | 6.1 years | $ | 41.50 |
(a)Reflects 11.9 million unvested options, net of anticipated forfeitures. Stock Awards TJX grants restricted stock units and performance share units under the Stock Incentive Plan. Restricted stock units, performance share units, and previously-granted performance-based stock awards are collectively referred to as stock awards. These awards were granted without a purchase price to the recipient and are subject to vesting conditions. Vesting conditions for performance share units and performance-based stock awards include specified performance criteria, generally for a period of three fiscal years. The grant date fair value of the stock awards is charged to income over the requisite service period during which the recipient must remain employed. The fair value of the stock awards is determined at date of grant in accordance with ASC Topic 718 and, for performance share units and performance-based stock awards, assumes that performance goals will be achieved at target. Performance share units, performance-based stock awards and related compensation costs recognized are adjusted, as applicable, for performance above or below the target specified in the award. During fiscal 2021, TJX determined that performance share unit awards granted during fiscal 2019 and fiscal 2020 were not expected to vest under the original performance vesting conditions. As a result, the expense previously recognized for these awards was reversed which decreased fiscal 2021 compensation expense by $55 million. In January 2021, for certain participants, a discretionary payout with respect to performance share unit awards granted during fiscal 2019 was approved and constituted a modification of the awards during fiscal 2021. Under ASC Topic 718 the modification requires that the fair value of these awards be adjusted to reflect the fair value on the date of the modification and resulted in a stock compensation charge of $16 million in fiscal 2021. A summary of the status of our nonvested stock awards and changes during fiscal 2021 is presented below:
| Stock Awards (in thousands) | Weighted Average Grant Date Fair Value
Nonvested at beginning of year | 3,445 |  | $ | 44.54 |
Granted | 857 |  | 56.24 |
Vested | (1,317) |  | 43.25 |
Forfeited | (14) |  | 48.04 |
Modification | (50) |  | 52.17 |
Nonvested at end of year | 2,921 |  | 51.36 |
There were 857,216 units with a weighted average grant date fair value of $56.24, granted in fiscal 2021, 1,001,849 units, with a weighted average grant date fair value of $53.20, granted in fiscal 2020, and 1,267,802 units, with a weighted average grant date fair value of $41.17, granted in fiscal 2019. The fair value of awards that vested was $57 million in fiscal 2021, $38 million in fiscal 2020, and $30 million in fiscal 2019. Other Awards TJX also awards deferred shares to its outside directors under the Stock Incentive Plan. As of the end of fiscal 2021, a total of 665,477 of these deferred shares were outstanding under the plan.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration